Strategic focus Target early-stage science and tech founders in healthcare, climate adaptation, and sustainable energy across universal and urgent markets, aligning with Future Positive Capital’s thesis to identify portfolio-worthy opportunities where impact and defensible technology drive value.

Global footprint Leverage Europe-based venture activity with a track record of backing international rounds (e.g., Dendra Systems, Cervest, Aerones), signaling openness to cross-border deals and strategic partnerships with multinational distributors, corporates, and growth-stage co-investors.

Portfolio synergies Position offerings to align with existing portfolio themes such as AI-powered life sciences, climate intelligence, and energy transition infrastructure, enabling co-investment, technology licensing, or pilot programs with familiar peers.

Public signals Capitalize on high-profile fundraisings and notable backers in the ecosystem (Peter Thiel, John Doerr, Marc Benioff, etc.) to open doors for co-investments, strategic partnerships, and validation during initial outreach to curators, accelerators, and corporate venture units.

Low-ops engagement Given a lean team and a broad portfolio, offer concise, outcomes-based collaboration options (pilot deployments, ROI-focused pilots, and measurable impact KPIs) to accelerate decision cycles and align with the firm’s emphasis on real-world performance alongside financial return.